您好,欢迎登录Mr.confs会先生官方网站!

ICDDPCTD 2021: 15. International Conference on Drug Development Process and Clinical Trial Design

时间:2021-04-08 至 2021-04-09

ICDDPCTD 2021: 15. International Conference on Drug Development Process and Clinical Trial Design
收藏0
ICDDPCTD 2021: 15. International Conference on Drug Development Process and Clinical Trial Design
会议时间:2021-04-08 至 2021-04-09
会议地点: Athens, Greece,Bangkok,Thailand 周边酒店预订

发票类型: 不支持开票
参会凭证:其它

门票信息
Participation Type Early Registration Fees Registration Fees
Non-Student Oral/Poster Presenter Registration € 350 € 400
Student Oral/Poster Presenter Registration € 300 € 350
Listener Registration € 250 € 300
Additional Paper Publication € 100
会议介绍

The International Research Conference Aims and Objectives

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.

ICDDPCTD 2021: 15. International Conference on Drug Development Process and Clinical Trial Design aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Drug Development Process and Clinical Trial Design. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Drug Development Process and Clinical Trial Design

Call for Contributions

Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Drug Development Process and Clinical Trial Design are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.

Guidelines for Authors

Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission Guideline, Abstract Submission Guideline and Author Information before submitting your paper.

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the Open Science Index, Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.

Special Journal Issues

ICDDPCTD 2021 has teamed up with the Special Journal Issue on Drug Development Process and Clinical Trial Design. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Selected Papers

  1. Public Service Ethics in Public Administration: An Empirical Investigation
    Kalsoom Sumra
  2. The Internet of Healthcare Things: A European Perspective and a Review of Ethical Concerns
    M. Emmanouilidou
  3. Corporate Social Responsibility Disclosure, Tax Aggressiveness and Sustainability Report Assurance: Evidence from Thailand
    Eko Budi Santoso, Kazia Laturette, Stanislaus Adnanto Mastan
  4. Application of Western and Islamic Philosophy to Business Ethics
    Elmamy Ahmedsalem
  5. Regulation, Co-Regulation and Self-Regulation of Civil Unmanned Aircrafts in Europe
    M. de Miguel Molina, V. Santamarina Campos, M. V. Segarra Oña, B. de Miguel Molina
  6. The Emerging Global Judicial Ethics: Issues and Problems
    Caroline Foulquier-Expert
  7. Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
    Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
  8. Corporate Governance and Corporate Social Responsibility: Research on the Interconnection of Both Concepts and Its Impact on Non-Profit Organizations
    Helene Eller
  9. Representations of Childcare Robots as a Controversial Issue
    Raya A. Jones
  10. Achieving Maximum Performance through the Practice of Entrepreneurial Ethics: Evidence from SMEs in Nigeria
    S. B. Tende, H. L. Abubakar
  11. Understanding Narrative Transformations of Ebola in Negotiations of Epidemic Risk
    N. W. Paul, M. Banerjee
  12. Net Regularity and Its Ethical Implications on Internet Stake Holders
    Nourhan Elshenawi
  13. The Interaction between Human and Environment on the Perspective of Environmental Ethics
    Mella Ismelina Farma Rahayu
  14. Creation of a Care Robot Impact Assessment
    E. Fosch-Villaronga
  15. Auditor with the Javanese Characters and Non Javanese in Audit Firm: Conflict of Interest
    Krisna Damayanti, Lilis Ardini
Faris Abachi University of Mosul, IQ
Ekatherina Charvalos IASO Clinic, GR
Athanasios Alexiou Ionian University, GR
Priyanka Sabharwal Health Partners Medical Group, US
Sivaramakrishna Yadavalli University of Houston, US
Paul Pistone California State University, San Marcos, US
Chuck Maclean Metropolitan State University, US
Manju Bhaskar National Institutes of Health, US
Cristina Richie East Carolina University, US
Terry Polen University of Maryland University College, US
Harry Xia Novartis Pharmaceuticals Corporation, US
Kal Ramnarayan Sapient Discovery, US
Gwo-Yu Chuang National Institutes of Health, US
Shashikant srivastava UT Southwestern Medical Center, US
Subeena Sood Medstar Health Research Institute, US
Zhengwu Lu Abbott Laboratories, US
Nael Barakat Grand Valley State University, US
RICK KELLER University of Tampa, US
Gihan Asaad National Research Centre, SA
Mai Abouhalawa National Research Center, Egypt, EG
Gohar Eslami Mazandaran University of Medical Sciences, IR
Sulaiman C T Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, IN
Aisha Aziz Jinnah University For Women, PK
Alon Weiss Sami Shamoon College of Engineering, IL
Fatemeh Kourkinejad Zahedan University of Medical Sciences, Zahedan, Iran, IR
Aziz Eftekhari Maragheh University of Medical Sciences , IR
Seyedeh Mahdieh Hashemi Mazandaran University of Medical Sciences, IR
Beáta Laki Medical School, University of Pécs, Hungary, HU
Jinning Hong Newman University, Birmingham, GB
Amina Ibrahim Kumamoto University , JP
会议日程
Abstracts/Full-Text Paper Submission Deadline   January 06, 2020
Notification of Acceptance/Rejection   January 28, 2020
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   March 08, 2021
Conference Dates   April 08-09, 2021
参会指南
会议地点
×